🔎 Trials Near Me

Akèy › Dyabèt Tip 2 › North Carolina › Havelock

Etid klinik pou Dyabèt Tip 2 nan Havelock, NC

13 etid pou Dyabèt Tip 2 ap chèche patisipan nan sit nan ak bò kote Havelock (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Ap rekriteFaz 3
  • Lucas Research, Inc., Morehead City · 15 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07064473

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

Ap rekriteFaz 3
  • Centricity Research - Morehead City, Morehead City · 15 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07754461

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Ap rekriteFaz 3
  • West Clinical Research, Morehead City · 15 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07282600

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Ap rekriteFaz 3
  • AURORA-2 Clinical Site, Morehead City · 15 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743450

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Ap rekriteFaz 3
  • Centricity Research Morehead City Multispeciality, Morehead City · 15 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Ap rekriteFaz 2
  • Lucas Research, Inc., Morehead City · 15 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Sep 14, 2026 · NCT06897475

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

Ap rekriteFaz 2
  • Lucas Research Inc, Morehead City · 15 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07296484

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Ap rekriteFaz 3
  • West Clinical Research, Morehead City · 15 mi lwen
Laj 18 a 99 · Tout sèks · Mizajou Sep 3, 2026 · NCT07684144

Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes

Ap rekrite
  • Centricity Research - Morehead City, Morehead City · 15 mi lwen
Laj 18 a 80 · Tout sèks · Mizajou Aug 28, 2026 · NCT07599982

Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus

Ap rekriteFaz 2
  • Lucas Research, Inc., Morehead City · 15 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Aug 17, 2026 · NCT07527650

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin

Ap rekriteFaz 3
  • Research Site, Morehead City · 15 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 4, 2026 · NCT07664553

Etid Dyabèt Tip 2 nan lòt vil

Lòt etid nan Havelock

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.